The Free Online 2014 HCPCS Code Lookup Website
HCPCS Q Codes (217 active, 26 terminated) >
  • 2014 HCPCS Q0035 Cardiokymography
  • 2014 HCPCS Q0081 Infusion therapy, using other than chemotherapeutic drugs, per visit
  • 2014 HCPCS Q0083 Chemotherapy administration by other than infusion technique only (eg subcutaneous, intramuscular, push), per visit
  • 2014 HCPCS Q0084 Chemotherapy administration by infusion technique only, per visit
  • 2014 HCPCS Q0085 Chemotherapy administration by both infusion technique and other techique(s) (eg subcutaneous, intramuscular, push), per visit
  • 2014 HCPCS Q0090 TERMINATED 12/31/2013 : Levonorgestrel-releasing intrauterine contraceptive system, (skyla), 13.5 mg
  • 2014 HCPCS Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
  • 2014 HCPCS Q0092 Set-up portable x-ray equipment
  • 2014 HCPCS Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens
  • 2014 HCPCS Q0112 All potassium hydroxide (koh) preparations
  • 2014 HCPCS Q0113 Pinworm examinations
  • 2014 HCPCS Q0114 Fern test
  • 2014 HCPCS Q0115 Post-coital direct, qualitative examinations of vaginal or cervical mucous
  • 2014 HCPCS Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
  • 2014 HCPCS Q0139 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
  • 2014 HCPCS Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram
  • 2014 HCPCS Q0161 Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0165 TERMINATED 12/31/2013 : Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0166 Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
  • 2014 HCPCS Q0167 Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0168 TERMINATED 12/31/2013 : Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0170 TERMINATED 12/31/2013 : Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0171 TERMINATED 12/31/2013 : Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0172 TERMINATED 12/31/2013 : Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0173 Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0174 Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0175 Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0176 TERMINATED 12/31/2013 : Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0178 TERMINATED 12/31/2013 : Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0179 TERMINATED 12/31/2011 : Ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0180 Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
  • 2014 HCPCS Q0181 Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • 2014 HCPCS Q0478 Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
  • 2014 HCPCS Q0479 Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0480 Driver for use with pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0481 Microprocessor control unit for use with electric ventricular assist device, replacement only
  • 2014 HCPCS Q0482 Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
  • 2014 HCPCS Q0483 Monitor/display module for use with electric ventricular assist device, replacement only
  • 2014 HCPCS Q0484 Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0485 Monitor control cable for use with electric ventricular assist device, replacement only
  • 2014 HCPCS Q0486 Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0487 Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0488 Power pack base for use with electric ventricular assist device, replacement only
  • 2014 HCPCS Q0489 Power pack base for use with electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0490 Emergency power source for use with electric ventricular assist device, replacement only
  • 2014 HCPCS Q0491 Emergency power source for use with electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0492 Emergency power supply cable for use with electric ventricular assist device, replacement only
  • 2014 HCPCS Q0493 Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0494 Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0495 Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0496 Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0497 Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0498 Holster for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0499 Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only
  • 2014 HCPCS Q0500 Filters for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0501 Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0502 Mobility cart for pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0503 Battery for pneumatic ventricular assist device, replacement only, each
  • 2014 HCPCS Q0504 Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
  • 2014 HCPCS Q0505 TERMINATED 3/31/2013 : Miscellaneous supply or accessory for use with ventricular assist device
  • 2014 HCPCS Q0506 Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
  • 2014 HCPCS Q0507 Miscellaneous supply or accessory for use with an external ventricular assist device
  • 2014 HCPCS Q0508 Miscellaneous supply or accessory for use with an implanted ventricular assist device
  • 2014 HCPCS Q0509 Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
  • 2014 HCPCS Q0510 Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
  • 2014 HCPCS Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
  • 2014 HCPCS Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
  • 2014 HCPCS Q0513 Pharmacy dispensing fee for inhalation drug(s); per 30 days
  • 2014 HCPCS Q0514 Pharmacy dispensing fee for inhalation drug(s); per 90 days
  • 2014 HCPCS Q0515 Injection, sermorelin acetate, 1 microgram
  • 2014 HCPCS Q1003 TERMINATED 3/31/2011 : New technology intraocular lens category 3 (reduced spherical aberration)
  • 2014 HCPCS Q1004 New technology intraocular lens category 4 as defined in federal register notice
  • 2014 HCPCS Q1005 New technology intraocular lens category 5 as defined in federal register notice
  • 2014 HCPCS Q2004 Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
  • 2014 HCPCS Q2009 Injection, fosphenytoin, 50 mg phenytoin equivalent
  • 2014 HCPCS Q2017 Injection, teniposide, 50 mg
  • 2014 HCPCS Q2025 TERMINATED 12/31/2010 : Fludarabine phosphate, oral, 1 mg
  • 2014 HCPCS Q2026 Injection, radiesse, 0.1 ml
  • 2014 HCPCS Q2027 TERMINATED 12/31/2013 : Injection, sculptra, 0.1 ml
  • 2014 HCPCS Q2028 Injection, sculptra, 0.5 mg
  • 2014 HCPCS Q2033 TERMINATED 12/31/2013 : Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)
  • 2014 HCPCS Q2034 Influenza virus vaccine, split virus, for intramuscular use (agriflu)
  • 2014 HCPCS Q2035 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
  • 2014 HCPCS Q2036 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
  • 2014 HCPCS Q2037 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
  • 2014 HCPCS Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
  • 2014 HCPCS Q2039 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (not otherwise specified)
  • 2014 HCPCS Q2040 TERMINATED 12/31/2011 : Injection, incobotulinumtoxin a, 1 unit
  • 2014 HCPCS Q2041 TERMINATED 12/31/2011 : Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
  • 2014 HCPCS Q2042 TERMINATED 12/31/2011 : Injection, hydroxyprogesterone caproate, 1 mg
  • 2014 HCPCS Q2043 Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
  • 2014 HCPCS Q2044 TERMINATED 12/31/2011 : Injection, belimumab, 10 mg
  • 2014 HCPCS Q2045 TERMINATED 12/31/2012 : Injection, human fibrinogen concentrate, 1 mg
  • 2014 HCPCS Q2046 TERMINATED 12/31/2012 : Injection, aflibercept, 1 mg
  • 2014 HCPCS Q2047 TERMINATED 12/31/2012 : Injection, peginesatide, 0.1 mg (for esrd on dialysis)
  • 2014 HCPCS Q2048 TERMINATED 12/31/2012 : Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
  • 2014 HCPCS Q2049 Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
  • 2014 HCPCS Q2050 Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10mg
  • 2014 HCPCS Q2051 TERMINATED 12/31/2013 : Injection, zoledronic acid, not otherwise specified, 1mg
  • 2014 HCPCS Q2052 Services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration
  • 2014 HCPCS Q3001 Radioelements for brachytherapy, any type, each
  • 2014 HCPCS Q3014 Telehealth originating site facility fee
  • 2014 HCPCS Q3025 TERMINATED 12/31/2013 : Injection, interferon beta-1a, 11 mcg for intramuscular use
  • 2014 HCPCS Q3026 TERMINATED 12/31/2013 : Injection, interferon beta-1a, 11 mcg for subcutaneous use
  • 2014 HCPCS Q3027 Injection, interferon beta-1a, 1 mcg for intramuscular use
  • 2014 HCPCS Q3028 Injection, interferon beta-1a, 1 mcg for subcutaneous use
  • 2014 HCPCS Q3031 Collagen skin test
  • 2014 HCPCS Q4001 Casting supplies, body cast adult, with or without head, plaster
  • 2014 HCPCS Q4002 Cast supplies, body cast adult, with or without head, fiberglass
  • 2014 HCPCS Q4003 Cast supplies, shoulder cast, adult (11 years +), plaster
  • 2014 HCPCS Q4004 Cast supplies, shoulder cast, adult (11 years +), fiberglass
  • 2014 HCPCS Q4005 Cast supplies, long arm cast, adult (11 years +), plaster
  • 2014 HCPCS Q4006 Cast supplies, long arm cast, adult (11 years +), fiberglass
  • 2014 HCPCS Q4007 Cast supplies, long arm cast, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4008 Cast supplies, long arm cast, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4009 Cast supplies, short arm cast, adult (11 years +), plaster
  • 2014 HCPCS Q4010 Cast supplies, short arm cast, adult (11 years +), fiberglass
  • 2014 HCPCS Q4011 Cast supplies, short arm cast, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4012 Cast supplies, short arm cast, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4013 Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster
  • 2014 HCPCS Q4014 Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass
  • 2014 HCPCS Q4015 Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster
  • 2014 HCPCS Q4016 Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4017 Cast supplies, long arm splint, adult (11 years +), plaster
  • 2014 HCPCS Q4018 Cast supplies, long arm splint, adult (11 years +), fiberglass
  • 2014 HCPCS Q4019 Cast supplies, long arm splint, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4020 Cast supplies, long arm splint, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4021 Cast supplies, short arm splint, adult (11 years +), plaster
  • 2014 HCPCS Q4022 Cast supplies, short arm splint, adult (11 years +), fiberglass
  • 2014 HCPCS Q4023 Cast supplies, short arm splint, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4024 Cast supplies, short arm splint, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4025 Cast supplies, hip spica (one or both legs), adult (11 years +), plaster
  • 2014 HCPCS Q4026 Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass
  • 2014 HCPCS Q4027 Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster
  • 2014 HCPCS Q4028 Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4029 Cast supplies, long leg cast, adult (11 years +), plaster
  • 2014 HCPCS Q4030 Cast supplies, long leg cast, adult (11 years +), fiberglass
  • 2014 HCPCS Q4031 Cast supplies, long leg cast, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4032 Cast supplies, long leg cast, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4033 Cast supplies, long leg cylinder cast, adult (11 years +), plaster
  • 2014 HCPCS Q4034 Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass
  • 2014 HCPCS Q4035 Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4036 Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4037 Cast supplies, short leg cast, adult (11 years +), plaster
  • 2014 HCPCS Q4038 Cast supplies, short leg cast, adult (11 years +), fiberglass
  • 2014 HCPCS Q4039 Cast supplies, short leg cast, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4040 Cast supplies, short leg cast, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4041 Cast supplies, long leg splint, adult (11 years +), plaster
  • 2014 HCPCS Q4042 Cast supplies, long leg splint, adult (11 years +), fiberglass
  • 2014 HCPCS Q4043 Cast supplies, long leg splint, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4044 Cast supplies, long leg splint, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4045 Cast supplies, short leg splint, adult (11 years +), plaster
  • 2014 HCPCS Q4046 Cast supplies, short leg splint, adult (11 years +), fiberglass
  • 2014 HCPCS Q4047 Cast supplies, short leg splint, pediatric (0-10 years), plaster
  • 2014 HCPCS Q4048 Cast supplies, short leg splint, pediatric (0-10 years), fiberglass
  • 2014 HCPCS Q4049 Finger splint, static
  • 2014 HCPCS Q4050 Cast supplies, for unlisted types and materials of casts
  • 2014 HCPCS Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)
  • 2014 HCPCS Q4074 Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
  • 2014 HCPCS Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis)
  • 2014 HCPCS Q4082 Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
  • 2014 HCPCS Q4100 Skin substitute, not otherwise specified
  • 2014 HCPCS Q4101 Apligraf, per square centimeter
  • 2014 HCPCS Q4102 Oasis wound matrix, per square centimeter
  • 2014 HCPCS Q4103 Oasis burn matrix, per square centimeter
  • 2014 HCPCS Q4104 Integra bilayer matrix wound dressing (bmwd), per square centimeter
  • 2014 HCPCS Q4105 Integra dermal regeneration template (drt), per square centimeter
  • 2014 HCPCS Q4106 Dermagraft, per square centimeter
  • 2014 HCPCS Q4107 Graftjacket, per square centimeter
  • 2014 HCPCS Q4108 Integra matrix, per square centimeter
  • 2014 HCPCS Q4109 TERMINATED 12/31/2010 : Skin substitute, tissuemend, per square centimeter
  • 2014 HCPCS Q4110 Primatrix, per square centimeter
  • 2014 HCPCS Q4111 Gammagraft, per square centimeter
  • 2014 HCPCS Q4112 Cymetra, injectable, 1cc
  • 2014 HCPCS Q4113 Graftjacket xpress, injectable, 1cc
  • 2014 HCPCS Q4114 Integra flowable wound matrix, injectable, 1cc
  • 2014 HCPCS Q4115 Alloskin, per square centimeter
  • 2014 HCPCS Q4116 Alloderm, per square centimeter
  • 2014 HCPCS Q4117 Hyalomatrix, per square centimeter
  • 2014 HCPCS Q4118 Matristem micromatrix, 1 mg
  • 2014 HCPCS Q4119 Matristem wound matrix, psmx, rs, or psm, per square centimeter
  • 2014 HCPCS Q4120 Matristem burn matrix, per square centimeter
  • 2014 HCPCS Q4121 Theraskin, per square centimeter
  • 2014 HCPCS Q4122 Dermacell, per square centimeter
  • 2014 HCPCS Q4123 Alloskin rt, per square centimeter
  • 2014 HCPCS Q4124 Oasis ultra tri-layer wound matrix, per square centimeter
  • 2014 HCPCS Q4125 Arthroflex, per square centimeter
  • 2014 HCPCS Q4126 Memoderm, dermaspan, tranzgraft or integuply, per square centimeter
  • 2014 HCPCS Q4127 Talymed, per square centimeter
  • 2014 HCPCS Q4128 Flex hd, allopatch hd, or matrix hd, per square centimeter
  • 2014 HCPCS Q4129 Unite biomatrix, per square centimeter
  • 2014 HCPCS Q4130 Strattice tm, per square centimeter
  • 2014 HCPCS Q4131 Epifix, per square centimeter
  • 2014 HCPCS Q4132 Grafix core, per square centimeter
  • 2014 HCPCS Q4133 Grafix prime, per square centimeter
  • 2014 HCPCS Q4134 Hmatrix, per square centimeter
  • 2014 HCPCS Q4135 Mediskin, per square centimeter
  • 2014 HCPCS Q4136 Ez-derm, per square centimeter
  • 2014 HCPCS Q4137 Amnioexcel or biodexcel, per square centimeter
  • 2014 HCPCS Q4138 Biodfence dryflex, per square centimeter
  • 2014 HCPCS Q4139 Amniomatrix or biodmatrix, injectable, 1 cc
  • 2014 HCPCS Q4140 Biodfence, per square centimeter
  • 2014 HCPCS Q4141 Alloskin ac, per square centimeter
  • 2014 HCPCS Q4142 Xcm biologic tissue matrix, per square centimeter
  • 2014 HCPCS Q4143 Repriza, per square centimeter
  • 2014 HCPCS Q4145 Epifix, injectable, 1 mg
  • 2014 HCPCS Q4146 Tensix, per square centimeter
  • 2014 HCPCS Q4147 Architect extracellular matrix, per square centimeter
  • 2014 HCPCS Q4148 Neox 1k, per square centimeter
  • 2014 HCPCS Q4149 Excellagen, 0.1 cc
  • 2014 HCPCS Q5001 Hospice or home health care provided in patient's home/residence
  • 2014 HCPCS Q5002 Hospice or home health care provided in assisted living facility
  • 2014 HCPCS Q5003 Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
  • 2014 HCPCS Q5004 Hospice care provided in skilled nursing facility (snf)
  • 2014 HCPCS Q5005 Hospice care provided in inpatient hospital
  • 2014 HCPCS Q5006 Hospice care provided in inpatient hospice facility
  • 2014 HCPCS Q5007 Hospice care provided in long term care facility
  • 2014 HCPCS Q5008 Hospice care provided in inpatient psychiatric facility
  • 2014 HCPCS Q5009 Hospice or home health care provided in place not otherwise specified (nos)
  • 2014 HCPCS Q5010 Hospice home care provided in a hospice facility
  • 2014 HCPCS Q9951 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9953 Injection, iron-based magnetic resonance contrast agent, per ml
  • 2014 HCPCS Q9954 Oral magnetic resonance contrast agent, per 100 ml
  • 2014 HCPCS Q9955 Injection, perflexane lipid microspheres, per ml
  • 2014 HCPCS Q9956 Injection, octafluoropropane microspheres, per ml
  • 2014 HCPCS Q9957 Injection, perflutren lipid microspheres, per ml
  • 2014 HCPCS Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9959 High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
  • 2014 HCPCS Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
  • 2014 HCPCS Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose